Pharmena S.A. (PHR) — Capital Reinvestment Ratio
Latest as of June 2023:
0.00x
Pharmena S.A. (PHR) has a Capital Reinvestment Ratio of 0.00x as of June 2023, meaning it reinvests 0% of its operating cash flow (zł44.83 Million) in capital expenditures (zł131.00K). See Pharmena S.A. (PHR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
zł44.83 Million
PLN
Capital Expenditures
zł131.00K
PLN
Data as of
Jun 2023
Most recent filing
Pharmena S.A. Capital Reinvestment Ratio (2011–2023)
This chart tracks Pharmena S.A.'s Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Pharmena S.A. (2011–2023)
Year-by-year Capital Reinvestment Ratio for Pharmena S.A. from 2011 to 2023. For live market cap and broader valuation context, see Pharmena S.A. market capitalisation.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | zł33.03 Million | zł314.00K | ▼ -92.3% |
| 2022 | 0.12x | zł1.82 Million | zł226.00K | ▲ +0.6% |
| 2018 | 0.12x | zł3.61 Million | zł446.00K | ▼ -61.2% |
| 2017 | 0.32x | zł619.00K | zł197.00K | ▲ +208.1% |
| 2011 | 0.10x | zł666.91K | zł68.89K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow